Navigation Links
FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, 'Enough Is Enough'
Date:11/29/2007

Dr. Karl Gruber Says New Rules for Sunscreen Are Necessary to Protect All

Consumers

LOS ANGELES, Nov. 29 /PRNewswire/ -- The U.S. Food and Drug Administration on Tuesday delayed its decision on adopting a new rule and rating system for over-the-counter sunscreen products, further delaying better sun protection for consumers everywhere, according to Dr. Karl Gruber, a surgical pathologist and expert in sun protection.

The new rule and rating system would require sunscreen manufacturers to provide more detailed information about their products' level of protection against damaging ultraviolet A (UVA) rays because the link between UVA exposure, melanoma and solar aging is compelling. The FDA has been wrestling with the UVA rule and rating issue and the need to update sunscreen regulations since 1999. On Tuesday, the agency extended its comment period on the proposed regulations to December 26, 2007.

"It is difficult to see how extending the comment period by a month for an issue that has been debated for eight years is going to make any difference -- except to deny consumers the information they need to make the best decisions about their own health," says Dr. Gruber, a physician who has studied carefully and fully endorses the FDA's proposed regulations.

Since 1978, over-the-counter sunscreen protection has been rated solely by SPF values, which only provides information on a product's level of protection from the sun's ultraviolet B (UVB) radiation that causes sunburn.

The American Academy of Dermatologists now recommends that consumers use a broad-spectrum sunscreen that blocks exposure to both UVA and UVB to help prevent skin cancer, the most prevalent of all types of cancers. More than 1 million new cases of skin cancer will be diagnosed in the U.S. this year alone, and more than 80 percent of these new cases could be prevented by protection from the sun's rays.(1)

Dr. Gruber regularly sees new cases of skin cancer in his Charleston, S.C. practice and subsequently created LUCA(TM) Sunscreen, which provides the maximum level of protection against both UVA and UVB rays. It is the only sun protection product in the U.S. to print on the bottle its critical wavelength value, the highest in the country and the most effective way to rate UVA protection.

LUCA Sunscreen is for adults and children and features a stabilized avobenzone formulation, which was uniquely created for LUCA as a light, cosmetically elegant alternative to zinc or titanium dioxide. It is water resistant, hypoallergenic, fragrance free and designed for use as a daily moisturizer. It is specially formulated for children and adults with sensitive skin. For more information, visit http://www.lucasunscreen.com.

(1) American Cancer Society


'/>"/>
SOURCE LUCA Sunscreen
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Proposes New Rules for Sunscreens
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
4. IOM workshop on less confusing drug labeling, Oct. 12
5. GSK Revises US Labeling for Avandia(R)
6. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
7. Microarray provides 3 genomic guides to breast cancer treatment decisions
8. Spectranetics to Appeal Decision in Patent Litigation
9. Canadas government funds $1.6M in modern geography to support public health decisions
10. Parents participation in medical decisions linked to self-efficacy
11. Decision-making by residents on-call has miniscule negative impact on patient care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... established the certification process to promote standards of excellence for the field of ... scheduled for March 22 – 25, 2018 in Orlando, Florida at the Omni ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology: